Nanoparticle 'Smart Bomb' To Target Cancer Cells Created From Novel Bee Venom Derivative

Main Category: Cancer / Oncology
Also Included In: Biology / Biochemistry;  Arthritis / Rheumatology;  Cardiovascular / Cardiology
Article Date: 03 Aug 2010 - 4:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:4 stars

4 (2 votes)

Healthcare Prof:1 star

1 (1 votes)

Article Opinions: 1 posts

New research in the FASEB Journal shows that a peptide derived from bee venom can deliver liposomes bearing drugs or diagnostic dyes to specific cells or tissues

The next time you are stung by a bee, here's some consolation: a toxic protein in bee venom, when altered, significantly improves the effectiveness liposome-encapsulated drugs or dyes, such as those already used to treat or diagnose cancer. This research, described in the August 2010 print issue of the FASEB Journal, shows how modified melittin may revolutionize treatments for cancer and perhaps other conditions, such as arthritis, cardiovascular disease, and serious infections.

"This type of transporter agent may help in the design and use of more personalized treatment regimens that can be selectively targeted to tumors and other diseases," said Samuel A. Wickline, Ph.D., a researcher involved in the work from the Consortium for Translational Research in Advanced Imaging and Nanomedicine (C-TRAIN) at the Washington University School of Medicine in St. Louis, Missouri.

To make this discovery, Wickline and colleagues designed and tested variations of the melittin protein to derive a stable compound that could be inserted into liposomal nanoparticles and into living cells without changing or harming them. They then tested the ability of this protein, or "transporter agent," to attach to different therapeutic compounds and enhance drug therapy without causing harmful side effects. In addition, their results suggest that the base compound which is used to create the transporter agent may improve tumor therapy as well.

"Our journal is abuzz in a hive of bee-related discoveries. Just last month, we published research showing for the first time how honey kills bacteria. This month, the Wickline study shows how bee venom peptides can form "smart bombs" that deliver liposomal nanoparticles directly to their target, without collateral damage," said Gerald Weissmann, M.D., Editor-in-Chief of the FASEB Journal.

Details:
Hua Pan, Jacob W. Myerson, Olena Ivashyna, Neelesh R. Soman, Jon N. Marsh, Joshua L. Hood, Gregory M. Lanza, Paul H. Schlesinger, and Samuel A. Wickline. Lipid membrane editing with peptide cargo linkers in cells and synthetic nanostructures. FASEB J. 2010 24: 2928-2937. doi: 10.1096/fj.09-153130

Source:
Cody Mooneyhan
Federation of American Societies for Experimental Biology

Article adapted by Medical News Today from original press release.
Visit our cancer / oncology section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Cody Mooneyhan. "Nanoparticle 'Smart Bomb' To Target Cancer Cells Created From Novel Bee Venom Derivative." Medical News Today. MediLexicon, Intl., 3 Aug. 2010. Web.
12 Feb. 2012. <http://www.medicalnewstoday.com/releases/196644.php>

APA
Cody Mooneyhan. (2010, August 3). "Nanoparticle 'Smart Bomb' To Target Cancer Cells Created From Novel Bee Venom Derivative." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/196644.php.

Please note: If no author information is provided, the source is cited instead.


Cancer / Oncology

What is Cancer?

Cancer is a class of diseases characterized by out-of-control cell growth. There are over 100 different types of cancer, and each is classified by the type of cell that is initially affected. Read more...

Most Popular Articles



Follow Our Cancer News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Cancer / Oncology Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »